Quantcast
 
New book by Larry Connors Click here Improve your trading - See how



TradingMarkets' 6 Stocks You Need To Know About Today

By TradingMarkets Research | TradingMarkets.com
Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS

Genentech reported  Q2 earnings of 0.30 vs a 0.26 forecast; revenues were in-line. Herceptin sales rose 23%. Tarceva sales were $10 million higher than analysts expected. DNA is up nearly $40 in the past 4 months. The company upped its guidance.

Pepsi (PEP | Quote | Chart | News | PowerRating) beat by 0.03 and said it was confident in its 2005 outlook.

Ameritrade (AMTD | Quote | Chart | News | PowerRating) beat by a penny, beat on revenues and issued in-line guidance.

Bank of America upgraded Dreamworks (DWA | Quote | Chart | News | PowerRating) to buy.

Biomet (BMET | Quote | Chart | News | PowerRating) was upgraded at Morgan Stanley, to overweight.

Colgate (CL | Quote | Chart | News | PowerRating) is selling its U.S. laundry brands for $60 million and will repatriate in $800 million in Q3, resulting in a one-time $35 million charge.


>> See more articles by TradingMarkets Research
Stocks RSS
Related Articles
More Related Articles >>
PREMIER SPONSORED LINKS
TRADE CENTER
 
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.